Mental Disorders

274 trials 116 recruiting

Filter these 274 trials by phase, country and sponsor.

Open in Search →

Psilocybin for hospitalized patients with treatment-resistant depression Recruiting

2022-501857-35-00 treatment-resistant depression 4 2024-04-22
Sleep and body temperature as markers of progression of Alzheimer's disease in Down syndrome. Recruiting

2023-506609-21-00 Down Syndrome. 4 2024-04-09
A research study to compare the antidepressant ability and safety of Samyr® tablets versus placebo tablets as an adjunct to additional antid… Recruiting

2024-513019-29-00 Major Depression Disorder 5 2024-03-22
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat) Recruiting

2024-514457-30-00 Schizophrenia 4 2024-02-26
Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder Recruiting

2022-500870-32-02 Post-traumatic stress disorder 4 2023-10-04
INSTA-MD: INflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder Recruiting

2022-501692-35-00 Major Depressive Disorder (MDD) 5 2023-09-21
Efficacy of melatonin, low-dose quetiapine, or placebo in patients with psychiatric disorders and comorbid insomnia: a randomized clinical t… Recruiting

2023-504728-24-00 Psychiatric disorder (ICD-10 F20-F69, F84, F90-F95) and 10 2023-09-15
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder. Recruiting

2024-518061-10-00 Severe Alcohol Use Disorder 4 2023-09-13
Can a single dose of psilocybin reduce alcohol intake in patients with alcohol use disorder? Recruiting

2024-517497-17-01 Alcohol Use Disorder 9 2023-09-01
Pharmacologic treatment augmentation in chronic depression “randomized, controlled, double blinded, phase II study” Recruiting

2024-512478-86-00 Diagnosis of chronic depression 4 2023-07-07
Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients Recruiting

2024-518226-32-00 Major Depression 6 2023-01-05
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting

2022-501428-45-00 Depression 5 2022-12-28
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) Recruiting

2024-517170-20-01 Depressive episode in bipolar disorder 6 2022-12-13
A phase 1b/2, multicenter, adaptive, double-blind, randomized, placebo-controlled study to assess the safety, tolerability, immunogenicity, … Recruiting

2022-500069-29-00 Alzheimer's disease 9 2022-11-02
Benzodiazepine stabilizing treatment for patients with benzodiazepine dependence undergoing opioid agonist therapy (BMX-BAR) Recruiting

2023-510404-44-02 Comorbid dependencies to benzodiazepines and opioids 5 2022-10-02
Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial Recruiting

2024-518212-40-00 Obsessive Compulsive Disorder (OCD) 5 2022-08-25
Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possib… Recruiting

2024-517747-31-00 Depressive disorder comorbid with cancer 4 2022-07-22
Ketamine study Recruiting

2024-519097-39-01 Negative and depressive symptoms in schizophrenia / sch 5 2022-06-23
Treatment of opioid dependency in patients with chronic pain: a comparative study between suboxone and methadone. Recruiting

2024-513924-41-01 Opioid use disorder (DSM-5); chronic non-cancer pain (I 6 2022-05-11
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting

2023-507372-42-00 Schizophrenia 4 2021-09-20
Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and… Recruiting

2023-506990-37-00 Alcohol addiction 5 2021-07-13
Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode Recruiting

2024-512445-17-00 mental disorders 4 2021-07-01
An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need … Recruiting

2024-518042-24-00 schizophrenia 6 2021-03-21
A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric an… Recruiting

2024-510720-38-00 Dementia with Lewy Bodies 4 2021-01-12